Literature DB >> 19952297

An algorithm for managing warfarin resistance.

Olusegun Osinbowale1, Monzr Al Malki, Andrew Schade, John R Bartholomew.   

Abstract

Some patients need higher-than-expected doses of warfarin (Coumadin) to get their international normalized ratio (INR) into the therapeutic range. The cause of warfarin resistance can be either acquired (eg, poor compliance, drug interactions, dietary interactions) or hereditary, but the genetic mechanisms of warfarin resistance are not well understood. This review offers an algorithm for the evaluation of patients with suspected warfarin resistance.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19952297     DOI： 10.3949/ccjm.76a.09062

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  11 in total

1.  How to use warfarin assays in patient management: analysis of 437 warfarin measurements in a clinical setting.

Authors:  Kyunghoon Lee; Hye In Woo; Oh Young Bang; Young-Keun On; June Soo Kim; Soo-Youn Lee
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

2.  Rheonix CARD(®) Technology: An Innovative and Fully Automated Molecular Diagnostic Device.

Authors:  Gwendolyn Spizz; Lincoln Young; Rubina Yasmin; Zongyuan Chen; Travis Lee; Deborah Mahoney; Xun Zhang; Greg Mouchka; Benjamin Thomas; Whitney Honey; Todd Roswech; Cristina McGuire; Richard Montagna; Peng Zhou
Journal:  Point Care       Date:  2012-03-01

3.  Warfarin resistance: possibilities to solve this problem. A case report.

Authors:  Halyna Mostbauer; Olga Nishkumay; Oksana Rokyta; Valeriia Vavryniuk
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

4.  Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein.

Authors:  Kelly E Beazley; Saman Eghtesad; Maria V Nurminskaya
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

5.  Dabigatran, electrical cardioversion and measuring the aPTT. A safety measure or an unnecessary assessment?

Authors:  N Rahmat; A Khan
Journal:  BMJ Case Rep       Date:  2013-06-19

6.  Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid.

Authors:  Tommaso Lomonaco; Silvia Ghimenti; Isabella Piga; Denise Biagini; Massimo Onor; Roger Fuoco; Fabio Di Francesco
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

7.  Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy.

Authors:  Jonathan M Yaghoubian; Jacob Adashek; Bahareh Yaghoubian-Yazi; Menachem Nagar; Nojan Toomari; Richard J Pietras; Uri M Ben-Zur
Journal:  Case Rep Cardiol       Date:  2017-07-30

Review 8.  Oral Anticoagulant Therapy-When Art Meets Science.

Authors:  Patricia Lorena Cîmpan; Romeo Ioan Chira; Mihaela Mocan; Florin Petru Anton; Anca Daniela Farcaş
Journal:  J Clin Med       Date:  2019-10-21       Impact factor: 4.241

9.  Analysis of Factors That Interrupt With INR Control in the First Anticoagulation Clinic Monitoring Jordanian Patients.

Authors:  Nairooz H Al-Momany; Zeid M Makahleh; Nadia A Al-Omari; Hana A Al-Sarayreh; Rawan O Momani
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

Review 10.  Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis.

Authors:  Jinhua Zhang; Zhijie Chen; Chunmei Chen
Journal:  Meta Gene       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.